Literature DB >> 31684734

More options for older patients with acute myeloid leukemia: venetoclax in combination with low dose cytarabine.

Ibrahim Aldoss1, Guido Marcucci2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31684734     DOI： 10.21037/cco.2019.09.03

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN： 2304-3865


× No keyword cloud information.
  3 in total

1.  Key immune-related gene ITGB2 as a prognostic signature for acute myeloid leukemia.

Authors:  Jie Wei; Xun-Jun Huang; Yan Huang; Ming-Yue Xiong; Xiang-You Yao; Zhi-Ning Huang; Si-Nian Li; Wei-Jie Zhou; Da-Lang Fang; Dong-Hong Deng; Peng Cheng
Journal:  Ann Transl Med       Date:  2021-09

2.  Identification of RHOBTB2 aberration as an independent prognostic indicator in acute myeloid leukemia.

Authors:  Peng Liu; Qinghai Ma; Hanxiang Chen; Li Zhang; Xiaoning Zhang
Journal:  Aging (Albany NY)       Date:  2021-06-01       Impact factor: 5.682

3.  Identification the prognostic value of glutathione peroxidases expression levels in acute myeloid leukemia.

Authors:  Jie Wei; Qiongni Xie; Xinran Liu; Chengyao Wan; Wenqi Wu; Kuiyan Fang; Yibin Yao; Peng Cheng; Donghong Deng; Zhenfang Liu
Journal:  Ann Transl Med       Date:  2020-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.